Heart failure drug study pulled before it even started
NCT ID NCT06176794
First seen Apr 30, 2026 · Last updated May 22, 2026 · Updated 4 times
Summary
This study aimed to see if an extended-release version of the water pill torsemide helps heart failure patients get rid of salt better than the standard version, especially after a salty lunch. It planned to enroll stable heart failure patients and compare urine salt levels over 24 hours. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Division of Nephrology, Hypertension & Renal Transplantation, University of Florida
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.